
Certain oral chemotherapies may cause hand-foot syndrome, but reducing the dose of the drug allows it to heal, an expert told CURE®.

Certain oral chemotherapies may cause hand-foot syndrome, but reducing the dose of the drug allows it to heal, an expert told CURE®.

I had been diagnosed with triple-negative breast cancer just three months after my mother passed away from the same disease.

The investigational drug LSTA1 is being explored for the treatment of osteosarcoma, which starts in the bones and accounts for 2% of childhood cancers.

A phase 3 trial determined that Tivdak showed “game-changing results” for certain patients with cervical cancer, an expert told CURE®.

While there is no prevention for lymphedema, there are ways to detect the condition early on, leading to better outcomes and quality of life.

The Princess of Wales' diagnosis of cancer after a successful procedure is not unusual — it even happened to me.

Managing and mitigating long-term side effects in prostate cancer survivors are “really important,” as it affects quality of life, an expert said.

Even the difficult experiences that we share, like the emotional and physical discomfort that comes with a cancer scan, can be a little easier when we know someone else has been through them, too.

When triple-negative breast cancer showed up at my door, I did what I could to prepare for the visit.

Subcutaneous administration of Opdivo, could increase efficiency and reduce wait times for patients, as one expert explains to CURE®.

When I received a diagnosis of uterine cancer, I felt like I was falling into Wonderland, just like Alice.

As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the needs of caregivers for adolescent and young adult patients with cancer.

As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the issues faced by adolescent and young adult patients with cancer as they age into adult care.

As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about how a cancer diagnosis ‘adds a new identity’ for adolescent and young adult patients.

As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the power of mindfulness practices such as yoga and meditation.

As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the current landscape of research for adolescent and young adult patients with cancer.

A two-time breast cancer survivor, I danced above the invitation it first offered me.

The Food and Drug Administration granted a full approval to Elahere for the treatment of certain patients with platinum-resistant gynecologic cancers.

Catherine, Princess of Wales, revealed that she was diagnosed with cancer after undergoing abdominal surgery in January.

Throughout my life, taking walks helped a lot with easing anxiety, so walking helped me when I received two diagnoses of cancer.

From Richard Simmons discussing his skin cancer to Nicole Eggert shaving her head, here’s what’s happening in the oncology space this week.

The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS.

I thought I would be fighting my battle with lymphoma alone, but my community of fellow cancer fighters stood with me.

Patients who underwent breast cancer radiation had higher rates of skin cancer, although altering their treatment plan is unnecessary, an expert said.

When life hands you cancer lemons, what flavored lemonade do you make?

One expert explains how caregivers are a vital part of the care team during a clinical trial.

A new robot-assisted nipple-conserving mastectomy is “not very different” in terms of patient experiences versus the traditional procedure.

During the CURE Educated Patient® Breast Cancer Summit, an expert discussed her professional and personal experience with side effect management in metastatic breast cancer.

An FDA committee voted that the benefits of Carvykti outweigh the risks for myeloma treatment, though concerns about secondary malignancies remain.

The waiting in between scans heightens my scanxiety, even though I've had no evidence of disease for 2 1/2 years.